Life sciences real estate was performing well before the COVID-19 pandemic struck earlier this year. For example, CBRE’s “U.S. Real Estate Market Outlook 2020” notes that the sector (including medical office) accounted for an annual average investment of $18.7 billion from 2014 to 2019.
However, the challenges and opportunities presented by the public health crisis have boosted interest and investment in the sector at a time when other areas of commercial real estate such as retail and office have struggled.
Adam Lasoff is a seasoned investment sales professional who is passionate about winning as a team and helping clients and colleagues meet their goals. In October of this year, he joined JLL as Managing Director with the Capital Markets Group after a decade at Cushman & Wakefield. Lasoff, who has been actively involved in NAIOP SFBA since 2013, has taken the reigns as 2021 Chapter President.
NAIOP SFBA hosted its Annual Capital Markets Update and Economic Forecast on Monday, November 16th. The exceptionally informative event featured a key note address and economic forecast by renown economist Christopher Thornburg, PhD, Founder, Beacon Economics. A summary of his key insights and predictions is provided here for MEMBERS ONLY ACCESS (must log-in to view).
PROP 15 DEFEATED BY CALIFORNIA VOTERS
The NAIOP SFBA Government Affairs Committee (GAC) has put together the following update for our members to stay informed about California State and San Francisco Bay Area local legislation. In addition to our Chapter's ongoing relationship with CBPA, which tracks legislation at the State level, New Deal Advisers teams with us to monitor and report on local Bay Area policies that affect commercial real estate.